Zhixiong Li

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Deubiquitination enzyme USP35 negatively regulates MAVS signaling to inhibit anti-tumor immunity.

Deubiquitination enzyme USP35 negatively regulates MAVS signaling to inhibit anti-tumor immunity.

Journal: Cell death & disease
Published: June 21, 2024

Cre recombinase promotes leukemogenesis in the presence of both homozygous and heterozygous FLT3-ITD.

Cre recombinase promotes leukemogenesis in the presence of both homozygous and heterozygous FLT3-ITD.

Journal: Leukemia
Published: January 29, 2024

Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.

Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemia.

Journal: Haematologica
Published: February 08, 2023

The short-term predictive value of CD4+ cells for combination therapy with high-dose dexamethasone and immunoglobulin in newly diagnosed primary immune thrombocytopenia patients.

The short-term predictive value of CD4+ cells for combination therapy with high-dose dexamethasone and immunoglobulin in newly diagnosed primary immune thrombocytopenia patients.

Journal: Thrombosis research
Published: May 08, 2022

Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal.

Proposed Diagnostic Criteria and Classification of Canine Mast Cell Neoplasms: A Consensus Proposal.

Journal: Frontiers in veterinary science
Published: August 09, 2021

New Insights into the Pathogenesis of Systemic Mastocytosis.

New Insights into the Pathogenesis of Systemic Mastocytosis.

Journal: International journal of molecular sciences
Published: March 31, 2021

A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation.

A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation.

Journal: Leukemia
Published: January 19, 2021

Flow cytometric characterization of acute leukemia reveals a distinctive "blast gate" of murine T-lymphoblastic leukemia/lymphoma.

Flow cytometric characterization of acute leukemia reveals a distinctive "blast gate" of murine T-lymphoblastic leukemia/lymphoma.

Journal: Oncotarget
Published: September 05, 2017

Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy.

Activation of TRKA receptor elicits mastocytosis in mice and is involved in the development of resistance to KIT-targeted therapy.

Journal: Oncotarget
Published: February 23, 2017

Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.

Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi‑1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.

Journal: Oncology reports
Published: November 10, 2016

Leukemogenic potency of the novel FLT3-N676K mutant.

Leukemogenic potency of the novel FLT3-N676K mutant.

Journal: Annals of hematology
Published: January 23, 2016

The heteromeric transcription factor GABP activates the ITGAM/CD11b promoter and induces myeloid differentiation.

The heteromeric transcription factor GABP activates the ITGAM/CD11b promoter and induces myeloid differentiation.

Journal: Biochimica et biophysica acta
Published: March 30, 2015
Showing 1-12 of 21

Last Updated: 09/26/2026